INSP - Inspire Medical Systems, Inc.... | Finranks

16.06.2026

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research

12.06.2026

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

MINNEAPOLIS, June 12, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2026 MedTech Innovation Spotlight on Friday, June 26, 2026.

11.06.2026

Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?

Alphatec focuses on a comprehensive spine surgery ecosystem to capture market share through integrated imaging and surgical solutions. Inspire Medical Systems dominates the sleep apnea neurostimulation market with a profitable, high-growth business model.

08.06.2026

Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff

Inspire Medical Systems faces a sharp revenue slowdown due to temporary CPT coding and CMS Project WISeR disruptions, not fundamental business weakness. INSP maintains a robust balance sheet with ~$400M in liquidity and zero debt, providing downside insulation and supporting a 1x EV/sales valuation at depressed prices. Competitive threats from Nyxoah and GLP-1 therapies are manageable, with IP litigation successes and GLP-1s potentially expanding INSP's addressable market.

03.06.2026

Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?

Inspire (INSP) reported earnings 30 days ago. What's next for the stock?

13.05.2026

Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript

05.05.2026

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Inspire Medical Systems, Inc. remains under pressure as Q1 revenue grew just 1.6% and management slashed 2026 guidance by up to 10%. INSP faces intensifying competition from GLP-1s and rival devices, reimbursement headwinds, and coding challenges with its new Inspire 5 system. Territory contraction and a shift to supporting existing accounts signal operational headwinds and a retreat from high-growth expansion.

Видео

No Data

There is no data to display

Повышения / Понижения рейтинга

Тикер	Фирма	Изменение рейтинга	Целевая цена	Дата
INSP	Oppenheimer	Outperform	undefined >> $175	December 8th 2025
INSP	Morgan Stanley	Equal Weight	undefined >> $130	December 2nd 2025
INSP	Truist	Buy	undefined >> $165	November 26th 2025
INSP	Wolfe Research	Outperform	undefined >> $180	November 25th 2025
INSP	Stifel	Buy	undefined >> undefined	November 24th 2025
INSP	Wells Fargo	Overweight	undefined >> $90	November 4th 2025
INSP	Jefferies	Hold	undefined >> $85	October 24th 2025
INSP	UBS	Neutral	undefined >> $89	September 22nd 2025

Пресс-релизы

16.06.2026

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research Highlights New Clinical Data, Technology Advancements, and Cardiovascular Outcomes Research

Inspire Medical Systems, Inc. (INSP)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?

Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff

Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?

Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP

Search stocks

Inspire Medical Systems, Inc. (INSP)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Inspire Medical Systems, Inc. (INSP)

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

Alphatec vs. Inspire Medical Systems: Which Healthcare Stock Is a Better Buy in 2026?

Inspire Medical: Golden Opportunity To Monetize A Fundamentally Mispriced Selloff

Why Is Inspire (INSP) Down 15.9% Since Last Earnings Report?

Inspire Medical Systems, Inc. (INSP) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Inspire: Why I'm Still Rating The Stock A 'Sell' After The Earnings Dip

Видео

No Data

Повышения / Понижения рейтинга

Пресс-релизы

Inspire Medical Systems, Inc. Announces Presence at SLEEP 2026 and Publication of PREDICTOR Study

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2026 MedTech Innovation Spotlight

Inspire Medical Systems, Inc. Announces First Quarter 2026 Financial Results and Updates 2026 Guidance

Inspire Medical Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Inspire Medical Systems, Inc. - INSP